- According to sources close to the matter, Johnson & Johnson (NYSE:JNJ) has tentatively agreed on an acquisition price for Actelion Ltd. (OTCPK:ALIOY). The negotiations are now focused on valuing the new R&D unit.
- J&J's most recent bid was $260/share.
- Source: Bloomberg
Johnson & Johnson agrees on price with Actelion; talks focused on valuation of R&D unit proceeding
Recommended For You
About JNJ Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| JNJ | - | - |
| Johnson & Johnson | ||